1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZKSCAN2 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA DRAXIN CTRPv2 pan-cancer AAC 0.14 6e-06
mRNA SMIM8 CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA EMC4 CTRPv2 pan-cancer AAC -0.15 7e-06
mRNA CSRNP2 CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA FAM57B CTRPv2 pan-cancer AAC 0.17 7e-06
mRNA PIAS4 CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA RBM6 CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA ZIC2 CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA N4BP2 CTRPv2 pan-cancer AAC 0.16 7e-06
Download CSV